The National Health Insurance House (CNAS) has published the conditions under which policyholders can benefit from 50% and 100% compensated vaccines based on an electronic prescription, but also details on how they are administered.
Vaccination. PHOTO Shutterstock
“These vaccines are included in sublist E of compensated drugs, in section E1 for those compensated 50% of the reference price and in section E2 for those compensated 100% of the reference price”states CNAS, in a statement.
The prescription of vaccines is carried out according to the therapeutic protocols developed by the specialized commissions of the Ministry of Health, by doctors of all specialties under contract with a health insurance company, following the consultation or upon discharge from the hospital, and the electronic medical prescription for these drugs is valid 30 days.
“The administration of sublist E vaccines is carried out by vaccinating doctors (family doctors, epidemiologists, infectious disease doctors, pediatricians or doctors from any other specialty who have a vaccinology certificate) or by vaccinating pharmacists in the case of the flu vaccine. The list of pharmacies where the flu vaccine can be administered is available on website of the Ministry of Health“, says the quoted source.
CNAS also reminds which are the categories of population that benefit from the prescription, release and settlement of immunological drugs used for the production of active immunity or for the prevention of communicable diseases.
Flu vaccine
Of flu vaccinel can benefit people aged 45 to 65 years, without chronic diseases, children aged 6 months to 19 years, pregnant women, people aged 19 to 65 years, with cardiovascular diseases chronic respiratory diseases, chronic kidney diseases, chronic liver diseases, chronic neurological diseases, metabolic diseases, oncological diseases, autoimmune diseases, congenital malformations, obesity, asplenia or in preparation for splenectomy, HIV/AIDS infection, immunosuppressive therapy, transplantation, immunosuppression congenital, people over 65 years old, specialized medical and sanitary and auxiliary staff.
Pneumococcal vaccine
Of pneumococcal vaccine can benefit children up to the age of 19 born before November 1, 2017, people aged between 19 and 65, with HIV/AIDS infection, asplenia or in preparation for splenectomy, sickle cell disease, chronic respiratory diseases, chronic kidney diseases, cochlear implant, congenital dysplasias of the inner ear, cerebrospinal fluid fistulas, oncological diseases, immunosuppressive therapy, transplantation, congenital immunosuppression, external ventricular drainage, diabetes, cardiovascular diseases, chronic liver diseases, leukemias, lymphomas, multiple myeloma, people over 65 years of age years, specialized medical-sanitary and auxiliary personnel.
Meningococcal vaccine
Of meningococcal vaccine can benefit people aged between 6 weeks and 65 years, with HIV/AIDS infection, asplenia or in preparation for splenectomy, sickle cell disease, cochlear implant, congenital dysplasia of the inner ear, cerebrospinal fluid fistulas, oncological diseases, immunosuppressive therapy, transplantation, immunosuppression, persistent deficiencies of complement components, patients receiving the recommendation for treatment with complement inhibitors (humanized monoclonal antibodies), for example patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis ( MGg) and neuromyelitis optica spectrum disorder (MNOD), people over 65 years of age;
papillomavirus (HPV) vaccine
Of papillomavirus (HPV) vaccine women between the ages of 19 and 45, people between the ages of 11 and 19 can benefit.
diphtheria-tetanopertussis vaccine
Pregnant women can benefit from the diphtheria-tetanus pertussis (whooping cough) vaccine (vaccination with the combined diphtheria-tetanus-acellular pertussis vaccine – dTpa, adsorbed is recommended), booster every 10 years from the previous dose, for adults, people with bone marrow transplantation/ of hematopoietic stem cells, people without a detectable titer of anti-pertussis antibodies (IgG), in the close entourage of transplant patients.
Hepatitis B vaccine
Of the vaccine hepatitis B can benefit dialysis persons not vaccinated before 1995 or chronic dialysis patients who require serologically documented booster doses, persons with HIV/AIDS infection, persons with transplants of organs, tissues or cells of human origin, persons receiving immunosuppressive therapy, direct contacts of confirmed cases with hepatitis B, people with chronic liver diseases – hepatitis C, cirrhosis, non-alcoholic liver, autoimmune hepatitis, persistent level of ALT/AST 2 times higher than normal, people with asplenia, people in the age group of 19 – 59 years with diabetes , for people over 60 years of age, the recommendation remains at the discretion of the attending physician, people with hereditary diseases predisposing to liver cirrhosis, Wilson’s disease, alpha-1 antitrypsin deficiency, hemochromatosis, specialized medical and sanitary personnel and unvaccinated sanitary assistants or with of antiHBs Ac less than 10 IU, after 3 doses of hepatitis B vaccine.
Varicella vaccine
Of varicella vaccine can benefit people without a detectable titer of antibodies (IgG) against varicella virus, in the close entourage of patients with transplants of organs, tissues or cells of human origin.
Measles, rubella, mumps vaccine
Of measles, rubella, whooping cough vaccine can benefit people with a bone marrow transplant, contacts without a detectable titer of antibodies (IgG) against the measles virus and/or against the rubella virus and/or against the mumps virus of people with transplants of organs, tissues or cells of human origin.
